{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:04:45Z","timestamp":1790157885313,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Here we report that PTEN contributes to DNA double-strand break (DSB) repair via homologous recombination (HR), as evidenced by (i) inhibition of HR in a reporter plasmid assay, (ii) enhanced sensitivity to mitomycin-C or olaparib and (iii) reduced RAD51 loading at IR-induced DSBs upon PTEN knockdown. No association was observed between PTEN-status and RAD51 expression either\n                    <jats:italic>in-vitro<\/jats:italic>\n                    or\n                    <jats:italic>in-vivo<\/jats:italic>\n                    in a tissue microarray of 1500 PTEN-deficient prostate cancer (PC) samples. PTEN depletion and sustained activation of AKT sequestered CHK1 in the cytoplasm, thus impairing the G2\/M-checkpoint after irradiation. Consistently, AKT inhibition recovered the G2\/M-checkpoint and restored HR efficiency in PTEN-depleted cells. We show that, although\n                    <jats:italic>PTEN<\/jats:italic>\n                    loss correlates with a worse prognosis, it may predict for improved response of PC patients to radiotherapy. Further, we provide evidence for the use of PTEN as a biomarker for predicting the response to PARP inhibitors as radiosensitizing agents in prostate cancer. Collectively, these data implicate PTEN in maintaining genomic stability by delaying G2\/M-phase progression of damaged cells, thus allowing time for DSB repair by HR. Furthermore, we identify PTEN-status in PC as a putative predictor of (i) radiotherapy response and (ii) response to treatment with PARP inhibitor alone or combined with radiotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-22289-7","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T09:21:05Z","timestamp":1519636865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["RETRACTED ARTICLE: Loss of PTEN-assisted G2\/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer"],"prefix":"10.1038","volume":"8","author":[{"given":"W. Y.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tennstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Volquardsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Oing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hube-Magg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Borgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dikomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-5729","authenticated-orcid":false,"given":"K.","family":"Rothkamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"22289_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-662-49651-0_1","volume":"198","author":"K Borgmann","year":"2016","unstructured":"Borgmann, K. et al. DNA Repair. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 198, 1\u201324, https:\/\/doi.org\/10.1007\/978-3-662-49651-0_1 (2016).","journal-title":"Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer"},{"key":"22289_CR2","doi-asserted-by":"publisher","first-page":"5706","DOI":"10.1128\/MCB.23.16.5706-5715.2003","volume":"23","author":"K Rothkamm","year":"2003","unstructured":"Rothkamm, K., Kruger, I., Thompson, L. H. & Lobrich, M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Molecular and cellular biology 23, 5706\u20135715 (2003).","journal-title":"Molecular and cellular biology"},{"key":"22289_CR3","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1093\/nar\/gkn347","volume":"36","author":"WY Mansour","year":"2008","unstructured":"Mansour, W. Y. et al. Hierarchy of nonhomologous end-joining, single-strand annealing and gene conversion at site-directed DNA double-strand breaks. Nucleic Acids Res 36, 4088\u20134098, https:\/\/doi.org\/10.1093\/nar\/gkn347 (2008).","journal-title":"Nucleic Acids Res"},{"key":"22289_CR4","doi-asserted-by":"publisher","first-page":"5249","DOI":"10.1093\/nar\/gkh842","volume":"32","author":"J Bentley","year":"2004","unstructured":"Bentley, J., Diggle, C. P., Harnden, P., Knowles, M. A. & Kiltie, A. E. DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining. Nucleic Acids Res 32, 5249\u20135259, https:\/\/doi.org\/10.1093\/nar\/gkh842 (2004).","journal-title":"Nucleic Acids Res"},{"key":"22289_CR5","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.molonc.2014.06.008","volume":"8","author":"A Kotter","year":"2014","unstructured":"Kotter, A. et al. Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells. Mol Oncol 8, 1616\u20131625, https:\/\/doi.org\/10.1016\/j.molonc.2014.06.008 (2014).","journal-title":"Mol Oncol"},{"key":"22289_CR6","first-page":"917","volume":"17","author":"KH Shin","year":"2006","unstructured":"Shin, K. H. et al. Abnormal DNA end-joining activity in human head and neck cancer. Int J Mol Med 17, 917\u2013924 (2006).","journal-title":"Int J Mol Med"},{"key":"22289_CR7","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1158\/0008-5472.CAN-11-3648","volume":"72","author":"JC Brenner","year":"2012","unstructured":"Brenner, J. C. et al. PARP-1 inhibition as a targeted strategy to treat Ewing\u2019s sarcoma. Cancer Res 72, 1608\u20131613, https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3648 (2012).","journal-title":"Cancer Res"},{"key":"22289_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913\u2013917, https:\/\/doi.org\/10.1038\/nature03443 (2005).","journal-title":"Nature"},{"key":"22289_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S146239940500904X","volume":"7","author":"NJ Curtin","year":"2005","unstructured":"Curtin, N. J. PARP inhibitors for cancer therapy. Expert reviews in molecular medicine 7, 1\u201320, https:\/\/doi.org\/10.1017\/S146239940500904X (2005).","journal-title":"Expert reviews in molecular medicine"},{"key":"22289_CR10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921, https:\/\/doi.org\/10.1038\/nature03445 (2005).","journal-title":"Nature"},{"key":"22289_CR11","doi-asserted-by":"publisher","first-page":"11135","DOI":"10.1074\/jbc.M113.457440","volume":"288","author":"L Feng","year":"2013","unstructured":"Feng, L., Fong, K. W., Wang, J., Wang, W. & Chen, J. RIF1 counteracts BRCA1-mediated end resection during DNA repair. The Journal of biological chemistry 288, 11135\u201311143, https:\/\/doi.org\/10.1074\/jbc.M113.457440 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"22289_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0900212","volume":"361","author":"PC Fong","year":"2009","unstructured":"Fong, P. C. et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. The New England journal of medicine 361, 123\u2013134, https:\/\/doi.org\/10.1056\/NEJMoa0900212 (2009).","journal-title":"The New England journal of medicine"},{"key":"22289_CR13","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1200\/jco.2009.26.9589","volume":"28","author":"PC Fong","year":"2010","unstructured":"Fong, P. C. et al. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 28, 2512\u20132519, https:\/\/doi.org\/10.1200\/jco.2009.26.9589 (2010).","journal-title":"Journal of clinical oncology: official journal of the American Society of Clinical Oncology"},{"key":"22289_CR14","doi-asserted-by":"publisher","unstructured":"Kari, V. et al. Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness. EMBO Rep, https:\/\/doi.org\/10.15252\/embr.201642352 (2016).","DOI":"10.15252\/embr.201642352"},{"key":"22289_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","volume":"133","author":"L Salmena","year":"2008","unstructured":"Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403\u2013414, https:\/\/doi.org\/10.1016\/j.cell.2008.04.013 (2008).","journal-title":"Cell"},{"key":"22289_CR16","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1158\/1078-0432.CCR-11-2189","volume":"18","author":"M Fraser","year":"2012","unstructured":"Fraser, M. et al. PTEN deletion in prostate cancer cells does not associate with loss of RAD51 function: implications for radiotherapy and chemotherapy. Clin Cancer Res 18, 1015\u20131027, https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2189 (2012).","journal-title":"Clin Cancer Res"},{"key":"22289_CR17","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1038\/sj.bjc.6604680","volume":"99","author":"P McCall","year":"2008","unstructured":"McCall, P., Witton, C. J., Grimsley, S., Nielsen, K. V. & Edwards, J. Is PTEN loss associated with clinical outcome measures in human prostate cancer? Br J Cancer 99, 1296\u20131301, https:\/\/doi.org\/10.1038\/sj.bjc.6604680 (2008).","journal-title":"Br J Cancer"},{"key":"22289_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2006.11.042","volume":"128","author":"WH Shen","year":"2007","unstructured":"Shen, W. H. et al. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157\u2013170, https:\/\/doi.org\/10.1016\/j.cell.2006.11.042 (2007).","journal-title":"Cell"},{"key":"22289_CR19","doi-asserted-by":"publisher","first-page":"5457","DOI":"10.1158\/0008-5472.CAN-09-4295","volume":"70","author":"B McEllin","year":"2010","unstructured":"McEllin, B. et al. PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors. Cancer Res 70, 5457\u20135464, https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4295 (2010).","journal-title":"Cancer Res"},{"key":"22289_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/emmm.200900041","volume":"1","author":"AM Mendes-Pereira","year":"2009","unstructured":"Mendes-Pereira, A. M. et al. Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. EMBO Mol Med 1, 315\u2013322, https:\/\/doi.org\/10.1002\/emmm.200900041 (2009).","journal-title":"EMBO Mol Med"},{"key":"22289_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1126\/science.1236188","volume":"341","author":"C Bassi","year":"2013","unstructured":"Bassi, C. et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 341, 395\u2013399, https:\/\/doi.org\/10.1126\/science.1236188 (2013).","journal-title":"Science"},{"key":"22289_CR22","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.4161\/cc.8.14.8947","volume":"8","author":"A Gupta","year":"2009","unstructured":"Gupta, A. et al. Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair. Cell Cycle 8, 2198\u20132210, https:\/\/doi.org\/10.4161\/cc.8.14.8947 (2009).","journal-title":"Cell Cycle"},{"key":"22289_CR23","doi-asserted-by":"publisher","first-page":"25207","DOI":"10.1074\/jbc.M300070200","volume":"278","author":"K Jiang","year":"2003","unstructured":"Jiang, K. et al. Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on Ser-345. The Journal of biological chemistry 278, 25207\u201325217, https:\/\/doi.org\/10.1074\/jbc.M300070200 (2003).","journal-title":"The Journal of biological chemistry"},{"key":"22289_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccr.2005.01.009","volume":"7","author":"J Puc","year":"2005","unstructured":"Puc, J. et al. Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer cell 7, 193\u2013204, https:\/\/doi.org\/10.1016\/j.ccr.2005.01.009 (2005).","journal-title":"Cancer cell"},{"key":"22289_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.ajpath.2012.04.026","volume":"181","author":"A Krohn","year":"2012","unstructured":"Krohn, A. et al. Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. The American journal of pathology 181, 401\u2013412, https:\/\/doi.org\/10.1016\/j.ajpath.2012.04.026 (2012).","journal-title":"The American journal of pathology"},{"key":"22289_CR26","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1002\/cncr.26169","volume":"117","author":"MR Cooperberg","year":"2011","unstructured":"Cooperberg, M. R., Hilton, J. F. & Carroll, P. R. The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117, 5039\u20135046, https:\/\/doi.org\/10.1002\/cncr.26169 (2011).","journal-title":"Cancer"},{"key":"22289_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/sj.cgt.7701050","volume":"14","author":"G Pappas","year":"2007","unstructured":"Pappas, G., Zumstein, L. A., Munshi, A., Hobbs, M. & Meyn, R. E. Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity. Cancer gene therapy 14, 543\u2013549, https:\/\/doi.org\/10.1038\/sj.cgt.7701050 (2007).","journal-title":"Cancer gene therapy"},{"key":"22289_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer cell 18, 11\u201322, https:\/\/doi.org\/10.1016\/j.ccr.2010.05.026 (2010).","journal-title":"Cancer cell"},{"key":"22289_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.radonc.2008.10.019","volume":"90","author":"U Kasten-Pisula","year":"2009","unstructured":"Kasten-Pisula, U. et al. The extreme radiosensitivity of the squamous cell carcinoma SKX is due to a defect in double-strand break repair. Radiother Oncol 90, 257\u2013264, https:\/\/doi.org\/10.1016\/j.radonc.2008.10.019 (2009).","journal-title":"Radiother Oncol"},{"key":"22289_CR30","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1093\/nar\/gkv160","volume":"43","author":"A Bakr","year":"2015","unstructured":"Bakr, A. et al. Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation. Nucleic Acids Res 43, 3154\u20133166, https:\/\/doi.org\/10.1093\/nar\/gkv160 (2015).","journal-title":"Nucleic Acids Res"},{"key":"22289_CR31","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2307\/3580029","volume":"151","author":"U Kasten","year":"1999","unstructured":"Kasten, U., Borgmann, K., Burgmann, P., Li, G. & Dikomey, E. Overexpression of human Ku70\/Ku80 in rat cells resulting in reduced DSB repair capacity with appropriate increase in cell radiosensitivity but with no effect on cell recovery. Radiat Res 151, 532\u2013539 (1999).","journal-title":"Radiat Res"},{"key":"22289_CR32","doi-asserted-by":"publisher","first-page":"57679","DOI":"10.18632\/oncotarget.11023","volume":"7","author":"A Bakr","year":"2016","unstructured":"Bakr, A. et al. Impaired 53BP1\/RIF1 DSB mediated end-protection stimulates CtIP-dependent end resection and switches the repair to PARP1-dependent end joining in G1. Oncotarget 7, 57679\u201357693, https:\/\/doi.org\/10.18632\/oncotarget.11023 (2016).","journal-title":"Oncotarget"},{"key":"22289_CR33","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1158\/1078-0432.CCR-07-1257","volume":"13","author":"T Schlomm","year":"2007","unstructured":"Schlomm, T. et al. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res 13, 6579\u20136584, https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-1257 (2007).","journal-title":"Clin Cancer Res"},{"key":"22289_CR34","doi-asserted-by":"crossref","unstructured":"Bubendorf, L. High-throughput microarray technologies: from genomics to clinics. European urology 40, 231\u2013238, doi:49777 (2001).","DOI":"10.1159\/000049777"},{"key":"22289_CR35","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/modpathol.2014.70","volume":"27","author":"A Krohn","year":"2014","unstructured":"Krohn, A. et al. Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 27, 1612\u20131620, https:\/\/doi.org\/10.1038\/modpathol.2014.70 (2014).","journal-title":"Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc"},{"key":"22289_CR36","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1158\/1078-0432.CCR-11-1251","volume":"17","author":"S Minner","year":"2011","unstructured":"Minner, S. et al. ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res 17, 5878\u20135888, https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1251 (2011).","journal-title":"Clin Cancer Res"},{"key":"22289_CR37","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (https:\/\/www.R-project.org\/, 2016)."}],"updated-by":[{"DOI":"10.1038\/s41598-026-72744-z","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22289-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22289-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:22:31Z","timestamp":1790155351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22289-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22289-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"15 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-72744-z","URL":"https:\/\/doi.org\/10.1038\/s41598-026-72744-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"3947"}}